{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:40:14Z","timestamp":1769172014541,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.clml.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T22:31:37Z","timestamp":1597703497000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["BCR-ABL1\u2013Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival"],"prefix":"10.1016","volume":"21","author":[{"given":"Kadriye Bahriye","family":"Payzin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaan","family":"Savasoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inci","family":"Alacacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Ebru","family":"Dalgic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul Bolat","family":"Kucukzeybek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin Orgen","family":"Calli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadi","family":"Bener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Payzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.08.006_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"1 suppl","key":"10.1016\/j.clml.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clml.2020.08.006_bib3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/j.clml.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1378\/chest.126.1_suppl.14S","article-title":"Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McGoon","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.clml.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1378\/chest.127.5.1836","article-title":"Pulmonary arterial hypertension: the key role of echocardiography","volume":"127","author":"Bossone","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.clml.2020.08.006_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0002-9343(92)90576-W","article-title":"Cardiac involvement in patients with myeloproliferative disorders","volume":"93","author":"Reisner","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.clml.2020.08.006_bib7","first-page":"245","article-title":"Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders","volume":"89","author":"Garypidou","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.08.006_bib8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1080\/10428190701493928","article-title":"Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis","volume":"48","author":"Altintas","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.08.006_bib9","first-page":"1779","article-title":"Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders","volume":"98","author":"Gupta","year":"2006","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.clml.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.leu.2404943","article-title":"Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status","volume":"22","author":"Cortelezzi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.08.006_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2003.08.013","article-title":"Functional and morphological cardiac changes in myeloproliferative disorders (clinical study)","volume":"97","author":"Kadikoylu","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clml.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10428194.2013.797083","article-title":"Pulmonary hypertension in patients with chronic myeloproliferative neoplasms","volume":"55","author":"Chebrek","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejim.2019.08.004","article-title":"Pulmonary hypertension in patients with myeloproliferative neoplasms: a large cohort of 183 patients","volume":"68","author":"Venton","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clml.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.21645","article-title":"The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera","volume":"106","author":"Tefferi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.08.006_bib15","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clml.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.rmed.2006.11.022","article-title":"Diagnosis and management of pulmonary hypertension over the past 100 years","volume":"101","author":"van Wolferen","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.clml.2020.08.006_bib17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.leukres.2008.09.026","article-title":"Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia","volume":"33","author":"Rasheed","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2020.08.006_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.120.3.801","article-title":"Unexplained pulmonary hypertension in chronic myeloproliferative disorders","volume":"120","author":"Dingli","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.clml.2020.08.006_bib19","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00277-016-2765-0","article-title":"Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience","volume":"95","author":"Mattar","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.08.006_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s002770100298","article-title":"Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia","volume":"80","author":"Fruehauf","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.08.006_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<130::AID-AJH8>3.0.CO;2-Z","article-title":"Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative disorders","volume":"60","author":"Garcia-Manero","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.08.006_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur Respir J"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020304213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020304213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:36:59Z","timestamp":1761871019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020304213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2152265020304213"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.08.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCR-ABL1\u2013Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}